StockWatch
·
Pharmaceuticals
Clarification20 Jun 2026, 04:50 pm

Astonea Labs Submits Revised Financial Results to BSE

AI Summary

Astonea Labs Ltd has submitted revised financial results for the financial year ended March 31, 2026, to the BSE. This submission follows observations from the BSE dated June 19, 2026, regarding the initial results filed on May 30, 2026. The company confirms that the standalone financial results were reviewed and approved by the Board of Directors and signed by an authorized director, Mr. Pardeep Dalal, in compliance with SEBI regulations. A certified true copy of the board resolution authorizing the signature is attached. The company also stated that there are no changes to the remaining information previously disclosed on May 30, 2026, including the XBRL filing. The independent auditor's report confirms the results are presented in accordance with listing regulations and provide a true and fair view.

Key Highlights

  • Astonea Labs resubmitted revised financial results for FY26.
  • Submission addresses BSE observations on initial May 30 filing.
  • Results approved by the Board and signed by authorized Director.
  • No changes to previously disclosed information.
  • Auditor confirms compliance and fair view of financial results.